Star7 S.p.A (STAR7) Fair Value & Analysis
Industrials · IT · Market cap €104M
Fair value as of: Jul 21, 2026
From 26 valuation models · updated 20 days ago
Fair value updated Jul 21, 2026, revised from €11.16 to €5.55 (−50.3%) since Jun 24, 2026. Share price +1.0% over the past month.
A solid business, but screening 42% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (€6.93). The favourable scenario is already priced in.
- Solid but not exceptional quality (66/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
55‑month range €5.55 – €11.90 · fair‑value band €4.16 – €6.93 · the €9.65 price screens above the €5.55 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Star7 S.p.A (STAR7) currently trades at €9.65, while our model-based Fair Value estimate is €5.55, implying the stock looks roughly 42.5% overvalued today. The Quality Score stands at 66/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Star7 S.p.A generated revenue of €117M at a net margin of 2.0%. Revenue declined 4.9% year over year. It earns a return on equity of 9.9%. Net debt stands at €21.1M. Fundamentals as of Jul 21, 2026
Our scenario range runs from €4.16 (bear case) to €6.93 (bull case); at €9.65, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 18% below its 52-week high and 79% above its 52-week low, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -35% fair-value upside, at -42%, STAR7 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: DCF Models (€18.69) versus Dividend Discount (€1.11). Highest evidence: Growth DCF (80).
Notify me when STAR7 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 65 · Market factors (momentum, volatility) 67
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Star7 S.p.A. provides engineering, product knowledge, global content, and printing services worldwide. It offers engineering services, including product development, electrical and electronic engineering, manufacturing engineering, and toolshop; product knowledge services, such as product information, spare parts catalogue, wiring diagrams, labour time, …
Full company description
Star7 S.p.A. provides engineering, product knowledge, global content, and printing services worldwide. It offers engineering services, including product development, electrical and electronic engineering, manufacturing engineering, and toolshop; product knowledge services, such as product information, spare parts catalogue, wiring diagrams, labour time, NATO codification, IT custom solution, and smart diagnostic; digital solutions comprising virtual reality, artificial intelligence, and mixed reality; training and e-learning, and virtual learning; and technical consulting, including service engineering, serviceability analysis, and technical staffing. The company also provides language services, such as translation, software localisation, copywriting and transcreation, machine translation, and interpreting; consulting on terminology management, translation memory setup, and web accessibility assessment; and dubbing, voice-over and subtitling for multimedia content. In addition, it offers digital and offset printing services; customized logistics and kitting, and warehousing; paperless solutions, physical stock, and data loading and burning; virtual product configuration, augmented reality, and immersive reality; and CGI, VFX and 3D art, graphic design, and video and animation. The company serves aerospace and defense, agriculture and construction equipment, air conditioning and household appliances, automotive and transportation, engineering and machine tools, fashion and retail, finance, food and beverage, information technology, software and technology, life sciences, media and publishing, public utilities, and sport and sports equipment industries. Star7 S.p.A. was founded in 2000 and is based in Alessandria, Italy.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Star7 S.p.A reported revenue of €116M in FY2025 versus €59.0M in FY2021, a compound +18.5%/yr. Reported net income was €2.4M in FY2025, compounding +2.0%/yr from FY2021.
STAR7 screens 42% overvalued. Compare with Cintas Corporation →
Peer Group
Specialty Business Services · 253 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Business Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Cintas Corporation CTAS | $206.25 | $95.30 | -54% |
| RELX PLC RELX | $33.70 | $32.49 | -4% |
| Thomson Reuters Corporation TRI | C$133.87 | C$70.40 | -47% |
| Copart, Inc CPRT | $27.61 | $28.59 | +4% |
| Global Payments Inc GPN | $80.49 | $69.67 | -13% |
| RB Global, Inc RBA | C$156.43 | C$49.14 | -69% |
| Brambles Limited BXB | A$18.79 | A$12.28 | -35% |
| UL Solutions Inc ULS | $87.76 | $33.62 | -62% |
| Wolters Kluwer N.V WKL | €62.56 | €103.99 | +66% |
| Aramark ARMK | $56.74 | $13.73 | -76% |
Compare Star7 S.p.A with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Star7 S.p.A (STAR7) overvalued or undervalued?
What is the fair value of STAR7?
What is the quality score of STAR7?
What is the revenue of Star7 S.p.A (STAR7)?
What is the net profit margin of STAR7?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Star7 S.p.A and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.